In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.

Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P ...

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

MENLO PARK, CA – Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leader in laboratory ... the company has seen its stock decline nearly 70% over the past year, though it maintains ...

In the last three months, 4 analysts have published ratings on Pacific Biosciences PACB, offering a diverse ... (typically once per quarter for each stock). Analysts usually derive their ...

Pacific Biosciences' Q4'24 results were another disappointment ... Growth in clinical and diagnostic markets will help, but not right away, and PACB is likely to remain below $100M in annualized ...